Charles N York II Insider Trading $AGLE Aeglea BioTherapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Charles N York II.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Charles N York II. Charles N York II is Chief Financial Officer and VP in Aeglea BioTherapeutics, Inc. ($AGLE).
Charles N York II in Aeglea BioTherapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Charles N York II: Chief Financial Officer and VP
Holdings: 10,828 shares
Current Value: $45,369
Latest Transaction: Feb 19 2020
$AGLE Market Capitalization: $56.54M
$AGLE Previous Close: $4.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Charles N York II in Aeglea BioTherapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2020 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Option Exercise | A | 8.15 | 126,000 | 1,026,900 | 126,000 | |
| Feb 22 2018 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Option Exercise | A | 6.31 | 92,100 | 581,151 | 92,100 | |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Buy | P | 4.76 | 10,241 | 48,700 | 34,787 | 24.5 K to 34.8 K (+41.72 %) |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Buy | P | 4.97 | 3,259 | 16,197 | 24,546 | 21.3 K to 24.5 K (+15.31 %) |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Buy | P | 4.59 | 6,500 | 29,855 | 21,287 | 14.8 K to 21.3 K (+43.96 %) |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Buy | P | 2.52 | 1,959 | 4,929 | 14,787 | 12.8 K to 14.8 K (+15.27 %) |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Buy | P | 4.28 | 2,000 | 8,568 | 12,828 | 10.8 K to 12.8 K (+18.47 %) |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Buy | P | 3.99 | 2,000 | 7,974 | 10,828 | 8.8 K to 10.8 K (+22.66 %) |
| Aug 24 2017 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Option Exercise | A | 3.10 | 58,500 | 181,350 | 58,500 | |
| Mar 22 2017 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Option Exercise | A | 8.03 | 90,000 | 722,700 | 90,000 | |
| May 19 2016 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Option Exercise | A | 7.28 | 55,000 | 400,400 | 55,000 | |
| Apr 12 2016 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Option Exercise | C | 0.00 | 2,037 | 0 | 0 | |
| Apr 12 2016 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Option Exercise | C | 0.00 | 9,523 | 0 | 0 | |
| Apr 12 2016 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Option Exercise | C | 0.00 | 1,324 | 0 | 0 | |
| Apr 12 2016 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Buy | C | 0.00 | 11,560 | 0 | 11,560 | 0 to 11.6 K |
| Apr 12 2016 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Buy | C | 0.00 | 1,324 | 0 | 8,828 | 7.5 K to 8.8 K (+17.64 %) |
Page: 1